Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies

• Published in: Seminars in arthritis and rheumatism Vol. 65; p. 152408
• Main Authors: Leclair, Valérie, Notarnicola, Antonella, Kryštůfková, Olga, Mann, Herman, Andersson, Helena, Diederichsen, Louise Pyndt, Vencovský, Jiri, Holmqvist, Marie, Lundberg, Ingrid E., Steele, Russell J., Hudson, Marie
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2024
• Subjects: Adult; Cancer; Deglutition Disorders - complications; Dysphagia; Humans; Idiopathic inflammatory myopathy; Medicin och hälsovetenskap; Mortality; Myositis - complications; Neoplasms - complications; Retrospective Studies; Idiopathic inflammatory myopathy; Dysphagia; Mortality; Cancer
• ISSN: 0049-0172; 1532-866X; 1532-866X
• DOI: 10.1016/j.semarthrit.2024.152408

The interplay between dysphagia, cancer, and mortality in idiopathic inflammatory myopathies (IIM) has not been carefully studied. The aim of this study was to investigate possible effect modification of cancer on the association between dysphagia and mortality in early IIM. A multi-center cohort of 230 adult IIM patients with dysphagia assessment within 6 months of disease onset was assembled. Crude mortality rates in IIM patients exposed or not to dysphagia were estimated for the 5-year period following cohort entry. To explore possible effect modification of cancer on the association between dysphagia and mortality, adjusted Cox models stratified on cancer status were performed as well as an interaction model. Mortality rates per 100 person-years for IIM patients exposed to dysphagia were 2.3 (95 %CI 1.0 to 4.5) in those without cancer compared to 33.3 (95 %CI 16.6 to 59.5) in those with cancer. In stratified Cox models, the main effect of dysphagia was HR 0.5 (95 %CI 0.2 to 1.5) in non-cancer and 3.1 (95 %CI 1.0 to 10.2) in cancer patients. In the interaction model, the combination of dysphagia and cancer yielded a HR of 6.4 (1.2 to 35.1). In this IIM cohort, dysphagia in non-cancer patients was not associated with increased mortality, while it was in presence of cancer, supporting effect modification of cancer on the association between dysphagia and mortality. This suggests that IIM patients with and without cancer differ and separate analyses for the two groups should be conducted when the outcome of interest is mortality.